Recombinant human C1 inhibitor for treatment of acute attacks of hereditary angioedema: a randomised, double-blind, placebo-controlled clinical trialM. Riedl,D. Moldovan,R. Levy,J. Baker,K. Obtulowicz,V Grivcheva-Panovska, D. McNeil,S. Andrejevic,A. Reshef,H. Farkas,H. Li, J. Bernstein, A. Davis,R. Lockey,W. Lumry,H. J. Wedner,T. Craig,R. Gower, T. Shriov,A. Relan,M. CicardiALLERGY（2013）引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
